53
Participants
Start Date
February 28, 2006
Primary Completion Date
June 30, 2010
Study Completion Date
August 31, 2010
bevacizumab
15 mg/kg IV every 3 weeks
cisplatin
75 mg/m2 IV every 3 weeks
pemetrexed
500 mg/m2 every 3 weeks
University of Texas Southwestern Medical Center, Dallas
Collaborators (1)
University of Chicago
OTHER
Columbia University
OTHER
Duke University
OTHER
University of Texas Southwestern Medical Center
OTHER